AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 241 min read$PG

Gama Paul sold $488K of PG

Gama Paul (CEO- Health Care) sold 3,396 shares of PROCTER & GAMBLE Co (PG) at $143.79 ($0.49M total) on 2026-08-20.

Original reporting
SEC EDGAR · Gama Paul
Published Aug 24, 2026, 7:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 7:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PG
Bearish
medium confidence
Mentioned
$PG
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGBearishLow
01

Why it matters

The disclosed sale is modest but may affect short-term sentiment.

02

Market read

Insider sale of $0.5M in a large-cap consumer staple may cause slight price movement.

03

What to watch

Sale price $143.79 is above recent market price, indicating possible profit taking.

Relevance 4/10Novelty 4/10Timing: post-filing 2026-08-24

Background

Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$PGBearishMedium confidence
Context

CEO Gama Paul sold 3,396 shares of Procter & Gamble for $488,310, reducing his stake to 40,832 shares.

Expected impact

Possible modest dip in PG price over the next few days.

Evidence & confidence

Sale size is modest relative to market cap, but insider activity often influences sentiment.

Market effects

Sector

Minimal impact on consumer staples sector.

Regional

U.S. market only.

Global

Low

Counterpoint

What could challenge this read

Insider sale may be routine portfolio diversification, not a negative signal.

Key entities

  • Company
    Procter & Gamble Co

    Consumer goods conglomerate (ticker PG).

  • Person
    Gama Paul

    CEO of Health Care division at Procter & Gamble.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PG insider trading history →

Related articles

OCT 10
$PGMed

Evercore Upgrades Procter & Gamble (PG) to Outperform with Raise

Evercore ISI upgraded Procter & Gamble (PG) to Outperform, raising its price target to $166. The firm cited improved U.S. execution, stabilizing category volumes, and positive reorganization outcomes. PG's fiscal first-quarter organic sales growth forecast was lifted to 3%, surpassing consensus estimates. The company offers a 2.84% dividend yield with a 61% payout ratio, and GuruFocus rates it modestly undervalued.

gurufocus.com3 min
OCT 10
$PGHigh

Procter & Gamble could face new cost problem

Procter & Gamble (PG) shares rose 1.5-2% after Evercore ISI upgraded it to Outperform with a $166 price target, citing improved market share and cost pressures. Evercore had been cautious due to PG's underperformance on Amazon and rising costs from oil, shipping, and tariffs, which squeezed margins. The upgrade suggests a 14% upside from the previous close.

finance.yahoo.com2 min
OCT 9
$PGHigh

Procter & Gamble could face new cost problem amid oil, shipping, tariff pressures

Procter & Gamble (PG) shares rose 1.5%-2% after Evercore ISI upgraded it to Outperform with a $166 price target, citing improved e-commerce performance and higher sales growth estimates. The firm had previously been cautious due to cost pressures from oil, shipping, and tariffs, but now expects PG to stop losing U.S. e-commerce market share and achieve 4% sales growth by fiscal 2027. PG's dividend yield is 2.9%, and the company has increased its dividend for 70 consecutive years.

aol.com2 min
OCT 7
$PGLow

Access Proposal at Procter & Gamble

Institutional Shareholder Services (ISS) recommended Procter & Gamble (P&G) shareholders vote 'for' a proposal opposed by the company's board. The proposal, brought by the National Legal and Policy Center (NLPC), aims to preserve shareholder access rights. P&G argues the vote is premature, as the SEC has proposed repealing the rule enabling such proposals. The vote is scheduled for October 13.

nlpc.org2 min